Evidence map›Paper›PMID 34680816›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Dissection of Highly Prevalent

Katharina Juraschek, Annemarie Käsbohrer, Burkhard Malorny, Stefan Schwarz, Diana Meemken, Jens André Hammerl

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genomic Characterization of Carbapenemase-ProducingAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Katharina JuraschekDepartment Biological Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn Str. 8-10, 10589 Berlin, Germany.
Annemarie KäsbohrerDepartment Biological Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn Str. 8-10, 10589 Berlin, Germany.ORCID 0000-0003-2966-2713
Burkhard MalornyDepartment Biological Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn Str. 8-10, 10589 Berlin, Germany.ORCID 0000-0002-3363-8225
Stefan SchwarzDepartment of Veterinary Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, 14163 Berlin, Germany.ORCID 0000-0002-6303-8212
Diana MeemkenDepartment of Veterinary Medicine, Institute of Food Safety and Food Hygiene, Freie Universität Berlin, 14163 Berlin, Germany.ORCID 0000-0002-4824-048X
Jens André HammerlDepartment Biological Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn Str. 8-10, 10589 Berlin, Germany.ORCID 0000-0002-6930-4358
Federal Institute for Risk Assessment · DEFreie Universität Berlin · DEUniversity of Veterinary Medicine Vienna · AT

Funding

German Federal Institute for Risk Assessment 43-001Horizon 2020 - ARDIG 773830
6 · The paper itself

Abstract

Plasmids are mobile genetic elements, contributing to the spread of resistance determinants by horizontal gene transfer. Plasmid-mediated quinolone resistances (PMQRs) are important determinants able to decrease the antimicrobial susceptibility of bacteria against fluoroquinolones and quinolones. The PMQR gene

Indexed as

E. colifluoroquinolonesIncXplasmidsqnrS1transferability

Identifiers

PMID34680816
PMCPMC8532951
OpenAlexW3206884989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.